The Drug-Induced Respiratory Disease Website

V - Myocarditis

V.a

Myocarditis (can be fulminate/fulminant)

5

Evidence level

definite

V.b

Eosinophilic myocarditis

1

Evidence level

low

VI - Cardiomyopathy

VI.a

Cardiomyopathy (acute, subacute, chronic)

1

Evidence level

low

VII - Cardiotoxicity

VII.a

‘Cardiotoxicity’

1

Evidence level

low

XII - Pericardial involvement

XII.n

Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)

2

Evidence level

possible

XIII - Thrombosis - Embolism

XIII.a

Pulmonary embolism - Venous thrombosis/thrombo-embolism

3

Evidence level

probable

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)

1

Evidence level

low

XXVIII - Large airway involvement

XXVIII.a

Angioedema (may cause UAO, asphyxia and death)

1

Evidence level

low

XXIX - Small airway involvement

XXIX.a

Bronchospasm - Wheezing - Asthma

1

Evidence level

low

XXXIII - Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)

XXXIII.b

Path: Lymphocytic myocarditis

1

Evidence level

low

XXXIII.c

Path: Eosinophilic myocarditis

1

Evidence level

low